57
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation

, , , , , & show all
Pages 2865-2872 | Published online: 11 Nov 2011

References

  • DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov2008777178218758474
  • DuncanRThe dawning era of polymer therapeuticsNat Rev Drug Discov2003234736012750738
  • PasutGVeroneseFMPolymer-drug conjugation, recent achievements and general strategiesProg Polym Sci200732933961
  • KangJSDeLucaPPLeeKCEmerging PEGylated drugsExpert Opin Emerg Drugs20091436338019453284
  • HarrisJMChessRBEffect of PEGylation on pharmaceuticalsNat Rev Drug Discov2003221422112612647
  • WangSZhangZLinXXuDSFengYDingKA polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heartGlycobiology20102047348420008963
  • ZhengQFengYXuDSLinXChenYZInfluence of sulfation on anti-myocardial ischemic activity of Ophiopogon japonicus polysaccharideJ Asian Nat Prod Res20091130632119431010
  • LinXXuDSFengYShenLDetermination of Ophiopogon japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatizationAnal Biochem200534217918515935322
  • LinXXuDSFengYLiSMLuZLShenLRelease-controlling absorption enhancement of enterally administered Ophiopogon japonicus polysaccharide by sodium caprate in ratsJ Pharm Sci2006952534254216937339
  • LinXWangSJiangYPoly(ethylene glycol)-radix ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivityEur J Pharm Biopharm20107623023720633648
  • RodriguezMCaiWJKostinSLucchesiBRSchaperJIschemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanism of myocardial ischemic injuryJ Mol Cell Cardiol20053872373315850566
  • LukyanovANHartnerWCTorchilinVPIncreased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbitsJ Control Release20049418719314684282
  • LinXWangZSunGShenLXuDFengYA sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of radix ophiopogonis polysaccharide in ratsBiomed Chromatogr20102482082520020416
  • XuDSFengYLinXDengHLFangJNDongQIsolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon JaponicusActa Pharmaceut Sin200540636639
  • ChiuHCKonakCKopeckovaPKopecekJEnzymatic degradation of poly(ethylene glycol)-modified dextransJ Bioactive Compat Polym19949388410
  • ManjulaBNTsaiAUpadhyaRSite-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chainBioconjug Chem20031446447212643758
  • PiquetGGattiMBarberoLTraversaSCacciaPEspositoPSet-up of large laboratory-scale chromatographic separations of poly(ethylene glycol) derivatives of the growth hormone-releasing factor 1–29 analogueJ Chromatogr A200294414114811831749
  • HindsKDKimSWEffects of PEG conjugation on insulin propertiesAdv Drug Deliv Rev20025450553012052712
  • DeFreesSWangZGXingRGlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coliGlycobiology20061683384316717104
  • HuhKMOoyaTLeeWKSupramolecular-structured hydrogels showing a reversible phase transition by inclusion complexation between poly(ethylene glycol) grafted dextran and α-cyclodextrinMacromolecules20013486578662
  • LukyanovANSawantRMHartnerWCTorchilinVPPEGylated dextran as long-circulating pharmaceutical carrierJ Biomater Sci Polymer Edn200415621630
  • HosteKBruneelDDe MarreADe SchrijverFSchachtESynthesis and characterization of poly(oxyethylene) modified dextransMacromol Rapid Commun199415697704
  • DuvalJMDelestreCCarreM-CHubertPDellacherieESynthesis and characterization of some covalent dextran-polyoxyethyleneglycol derivativesCarbohyd Polym199115233242
  • RoggeTMStevensCVVandammeAApplication of ethoxylated inulin in water-blown polyurethane foamsBiomacromolecules200561992199716004437
  • SunGLinXWangZFengYXuDShenLPEGylated inulin as long-circulating pharmaceutical carrierJ Biomater Sci Polym Ed20112242944120566038
  • WangZJLinXShenLFengYXuDSRuanKFPharmacokinetics of a long-circulating PEGylated radix ophiopogonis polysaccharideActa Pharmaceut Sin2011461012571261
  • LinXWangZJWangSComparison of tissue distribution of a PEGylated radix ophiopogonis polysaccharide in mice with normal and ischemic myocardiumEur J Pharm Biopharm201179362162621784151
  • CharmanSASegraveAMEdwardsGAPorterCJHSystemic availability and lymphatic transport of human growth hormone administered by subcutaneous injectionJ Pharm Sci20008916817710688746
  • SupersaxoAHeinWRSteffenHEffect of molecular weight on the lymphatic absorption of water-soluble compounds following subcutaneous administrationPharm Res199071671692137911
  • SupersaxoAHeinWGallatiHSteffenHRecombinant human interferon alpha-2a: delivery to lymphoid tissue by selected modes of applicationPharm Res198854724763244653
  • PorterCJCharmanSALymphatic transport of proteins after subcutaneous administrationJ Pharm Sci20008929731010707011
  • YamaokaTTabataYIkadaYDistribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to miceJ Pharm Sci1994836016068046623
  • GreenwaldRBGilbertCWPendriAConoverCDXiaJMartinezADrug delivery systems: water soluble taxol 2′-poly(ethylene glycol) ester prodrugs-design and in vivo effectivenessJ Med Chem1996394244318558510
  • VenturoliDRippeBFicoll and dextran vs globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformabilityAm J Physiol2005288605613
  • ArendshorstWJNavarLGRenal circulation and glomerular hemodynamicsSchrierRWGottshalkCWDiseases of the KidneyBoston, MALittle, Brown198865